Abstract |
To test whether longer duration of treatment of asymptomatic bacteriuria in old age could improve the efficacy of cotrimoxazole therapy, three regimens were given to 75 ambulant bacteriuric residents of a retirement home, aged greater than or equal to 68 years. The groups and regimens were: A:23 subjects (160/800 mg b.i.d. orally x 3 days). B: 24 subjects (160/800 mg i.m. x 10 days); C: 28 subjects (160/800 mg b.i.d. orally x 20 days). One week, one month and five months post- therapy urines were negative in 78.3% vs 52.9% vs 42.9% of group A, in 54.2% vs 56.5% vs 50% of group B and in 57.1% vs 60.7% vs 68% of group C subjects respectively. The data indicate that: 1) the efficacy of any schedule is only moderate irrespective of the presence of antibody-coated bacteria in urine; 2) a 3-day course appears more effective at one week post- therapy; 3) at one and five months greater than or equal to 50% of the subjects were infection-free, the 20 day treatment resulting in fewer failures; 4) subjects with long-term eradication had no mobility problem, low serum creatinine and a normal urinary tract as seen by ultrasound.
|
Authors | A S Dontas, H Giamarellou, M Staszewska-Pistoni, G Petrikkos, M Iakovou, V Tzias |
Journal | Journal of chemotherapy (Florence, Italy)
(J Chemother)
Vol. 4
Issue 2
Pg. 114-8
(Apr 1992)
ISSN: 1120-009X [Print] England |
PMID | 1629748
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Trimethoprim, Sulfamethoxazole Drug Combination
- Creatinine
|
Topics |
- Administration, Oral
- Aged
- Aged, 80 and over
- Bacteriuria
(blood, drug therapy)
- Creatinine
(blood)
- Drug Administration Schedule
- Escherichia coli
(isolation & purification)
- Escherichia coli Infections
(blood, drug therapy, urine)
- Female
- Humans
- Injections, Intramuscular
- Male
- Trimethoprim, Sulfamethoxazole Drug Combination
(administration & dosage, adverse effects)
|